Kimyrsa
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $171,197 | 1,307 | 658 |
| 2023 | $320,139 | 3,030 | 1,502 |
| 2022 | $500,566 | 4,552 | 2,196 |
| 2021 | $86,456 | 1,746 | 1,034 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $409,910 | 210 | 38.0% |
| Food and Beverage | $279,392 | 10,076 | 25.9% |
| Consulting Fee | $240,627 | 46 | 22.3% |
| Travel and Lodging | $74,428 | 272 | 6.9% |
| Unspecified | $40,639 | 2 | 3.8% |
| Education | $33,362 | 29 | 3.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Anchoring Intermittent long acting antimicrobials to medication for opiod use disorder treatment to facilitate structure transitions of care for people who use drugs admitted to the hospital with invasive infections (AIM-STOP) | Melinta Therapeutics, LLC | $39,139 | 0 |
| Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients | Melinta Therapeutics, LLC | $1,500 | 0 |
Top Doctors Receiving Payments for Kimyrsa — Page 155
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hospitalist | Macon, GA | $13.00 | 1 |
| , DO | Student in an Organized Health Care Education/Training Program | Macon, GA | $13.00 | 1 |
| , MD | Internal Medicine | Las Vegas, NV | $13.00 | 1 |
| , APRN | Family | Marianna, FL | $12.99 | 1 |
| , ARNP | Family | Marianna, FL | $12.99 | 1 |
| , M.D | Family Medicine | Marianna, FL | $12.99 | 1 |
| , NP | Nurse Practitioner | Atlanta, GA | $12.97 | 1 |
| , DO | Family Medicine | Moultrie, GA | $12.96 | 1 |
| , MD | Family Medicine | Moultrie, GA | $12.96 | 1 |
| , PA | Physician Assistant | Moultrie, GA | $12.96 | 1 |
| , DO | Family Medicine | Moultrie, GA | $12.96 | 1 |
| , D.O | Internal Medicine | Jefferson City, MO | $12.95 | 1 |
| , M.D | Internal Medicine | Jefferson City, MO | $12.95 | 1 |
| , DO | Internal Medicine | Jefferson City, MO | $12.95 | 1 |
| , MD | Internal Medicine | Hammond, LA | $12.94 | 1 |
| , NP-C | Adult Health | Colorado Springs, CO | $12.94 | 1 |
| , M.D | Internal Medicine | Jefferson City, MO | $12.94 | 1 |
| , DPM | Podiatrist | Tampa, FL | $12.92 | 1 |
| , MD | Internal Medicine | Las Vegas, NV | $12.90 | 1 |
| , AG-ACNP | Gerontology | Las Vegas, NV | $12.90 | 1 |
| , M.D | Hospitalist | Edmond, OK | $12.88 | 1 |
| , MD | Internal Medicine | Houston, TX | $12.87 | 1 |
| , DPM | Foot & Ankle Surgery | Louisville, KY | $12.85 | 1 |
| , DPM | Podiatrist | Ponte Vedra, FL | $12.82 | 1 |
| , MD | Emergency Medicine | Solvang, CA | $12.73 | 1 |
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 3,950
- Transactions 10,635
About Kimyrsa
Kimyrsa is a drug associated with $1.1M in payments to 3,950 healthcare providers, recorded across 10,635 transactions in the CMS Open Payments database. The primary manufacturer is Melinta Therapeutics, LLC.
Payment data is available from 2021 to 2024. In 2024, $171,197 was paid across 1,307 transactions to 658 doctors.
The most common payment nature for Kimyrsa is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($409,910, 38.0% of total).
Kimyrsa is associated with 2 research studies, including "Anchoring Intermittent long acting antimicrobials to medication for opiod use disorder treatment to facilitate structure transitions of care for people who use drugs admitted to the hospital with invasive infections (AIM-STOP)" ($39,139).